keyword
Keywords Metabolically Supported Chemot...

Metabolically Supported Chemotherapy

https://read.qxmd.com/read/38727260/bone-marrow-adipose-tissue
#1
REVIEW
Elena Marinelli Busilacchi, Erika Morsia, Antonella Poloni
Bone marrow (BM) acts as a dynamic organ within the bone cavity, responsible for hematopoiesis, skeletal remodeling, and immune system control. Bone marrow adipose tissue (BMAT) was long simply considered a filler of space, but now it is known that it instead constitutes an essential element of the BM microenvironment that participates in homeostasis, influences bone health and bone remodeling, alters hematopoietic stem cell functions, contributes to the commitment of mesenchymal stem cells, provides effects to immune homeostasis and defense against infections, and participates in energy metabolism and inflammation...
April 23, 2024: Cells
https://read.qxmd.com/read/38714665/longitudinal-molecular-profiling-elucidates-immunometabolism-dynamics-in-breast-cancer
#2
JOURNAL ARTICLE
Kang Wang, Ioannis Zerdes, Henrik J Johansson, Dhifaf Sarhan, Yizhe Sun, Dimitris C Kanellis, Emmanouil G Sifakis, Artur Mezheyeuski, Xingrong Liu, Niklas Loman, Ingrid Hedenfalk, Jonas Bergh, Jiri Bartek, Thomas Hatschek, Janne Lehtiö, Alexios Matikas, Theodoros Foukakis
Although metabolic reprogramming within tumor cells and tumor microenvironment (TME) is well described in breast cancer, little is known about how the interplay of immune state and cancer metabolism evolves during treatment. Here, we characterize the immunometabolic profiles of tumor tissue samples longitudinally collected from individuals with breast cancer before, during and after neoadjuvant chemotherapy (NAC) using proteomics, genomics and histopathology. We show that the pre-, on-treatment and dynamic changes of the immune state, tumor metabolic proteins and tumor cell gene expression profiling-based metabolic phenotype are associated with treatment response...
May 7, 2024: Nature Communications
https://read.qxmd.com/read/38697305/racial-disparities-in-evidence-based-management-of-metabolic-dysfunction-associated-steatotic-liver-disease-in-patients-with-type-2-diabetes
#3
JOURNAL ARTICLE
Anastasia-Stefania Alexopoulos, Alice Parish, Maren Olsen, Bryan C Batch, Cynthia A Moylan, Matthew J Crowley
OBJECTIVE: To assess frequency of evidence-based management (EBM) of metabolic dysfunction-associated steatotic liver disease (MASLD) in patients with type 2 diabetes (T2D), and to examine for racial/ethnic disparities in the receipt of EBM. METHODS: We conducted a cross-sectional analysis of patients with T2D and presumptive MASLD in an academic healthcare system between 2019 and 2021. Presumptive MASLD was defined as at least one ALT value ≥30 U/L with exclusions for alcohol overuse, viral hepatitis, liver transplantation, chemotherapy use, and liver disease other than MASLD...
April 30, 2024: Endocrine Practice
https://read.qxmd.com/read/38690893/bactericidal-and-sterilizing-activity-of-sudapyridine-clofazimine-tb47-combined-with-linezolid-or-pyrazinamide-in-a-murine-model-of-tuberculosis
#4
JOURNAL ARTICLE
Wei Yu, Yanan Ju, Xingli Han, Xirong Tian, Jie Ding, Shuai Wang, H M Adnan Hameed, Yamin Gao, Lei Li, Yongguo Li, Nanshan Zhong, Tianyu Zhang
As an obligate aerobe, Mycobacterium tuberculosis relies on its branched electron transport chain (ETC) for energy production through oxidative phosphorylation. Regimens targeting ETC exhibit promising potential to enhance bactericidal activity against M. tuberculosis and hold the prospect of shortening treatment duration. Our previous research demonstrated that the bacteriostatic drug candidate TB47 (T) inhibited the growth of M. tuberculosis by targeting the cytochrome bc1 complex and exhibited synergistic activity with clofazimine (C)...
May 1, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38668455/perfluorooctanesulfonic-acid-alters-pro-cancer-phenotypes-and-metabolic-and-transcriptional-signatures-in-testicular-germ-cell-tumors
#5
JOURNAL ARTICLE
Raya I Boyd, Doha Shokry, Zeeshan Fazal, Brayden C Rennels, Sarah J Freemantle, Michael R La Frano, Gail S Prins, Zeynep Madak Erdogan, Joseph Irudayaraj, Ratnakar Singh, Michael J Spinella
The potential effects of poly- and perfluoroalkyl substances (PFAS) are a recently emergent human and environmental health concern. There is a consistent link between PFAS exposure and cancer, but the mechanisms are poorly understood. Although epidemiological evidence supporting PFAS exposure and cancer in general is conflicting, there is relatively strong evidence linking PFAS and testicular germ cell tumors (TGCTs). However, no mechanistic studies have been performed to date concerning PFAS and TGCTs. In this report, the effects of the legacy PFAS perfluorooctanesulfonic acid (PFOS) and the newer "clean energy" PFAS lithium bis(trifluoromethylsulfonyl)imide (LiTFSi, called HQ-115), on the tumorigenicity of TGCTs in mice, TGCT cell survival, and metabolite production, as well as gene regulation were investigated...
March 22, 2024: Toxics
https://read.qxmd.com/read/38666811/considerations-for-medical-nutrition-therapy-management-of-the-critically-ill-patient-with-hematological-malignancies-a-narrative-review
#6
REVIEW
Juan Carlos Lopez-Delgado, Jayshil J Patel, Christian Stoppe, Stephen A McClave
Patients with hematological malignancies (HMs) are more frequently admitted now than in the past to the intensive care unit (ICU) due to more aggressive approaches in primary therapy of HMs and the need for critical care support. Pathophysiological alterations derived from HMs and the different hematological therapies, such as chemotherapy, negatively affect gastrointestinal (GI) function, metabolism, and nutrition status. Further, malnutrition strongly influences outcomes and tolerance of the different hematological therapies...
April 26, 2024: Nutrition in Clinical Practice
https://read.qxmd.com/read/38641949/neuropsychological-assessment-intervention-and-best-practices-for-women-with-non-central-nervous-system-cancer-a-scoping-review-of-current-standards
#7
REVIEW
Hannah B VanLandingham, Rachael L Ellison, Nataliya Turchmanovych-Hienkel, Demy Alfonso, Alison Oh, Erin T Kaseda, Karen Basurto, Phoebe K Y Tse, Humza Khan
Objective: Existing literature has sought to characterize the broad cognitive impact of non-central nervous system cancer and its treatment, including chemotherapy, radiation, surgery, and hormonal regulation. However, despite the frequency of women that are diagnosed with breast and gynecological cancer, there is limited research on the specific cognitive experiences of women undergoing cancer treatment. Presently, the current literature lacks concise guidance for neuropsychologists to support the cognitive health of women facing cancer, despite the acknowledged impact of cancer interventions and chronic illness on cognitive outcomes...
April 20, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/38576712/a-rare-case-of-primary-cardiac-diffuse-large-b-cell-lymphoma-imaged-with-18-f-fdg-pet-ct-a-case-report-and-literature-review
#8
Wenpeng Huang, Zuohuan Zheng, Yongbai Zhang, Yongkang Qiu, Yushuo Peng, Qi Yang, Wei Wang, Lei Kang
BACKGROUND: One of the exceptionally rare forms of non-Hodgkin's lymphoma (NHL) is primary cardiac lymphoma (PCL). The principal clinical manifestation in patients with PCL involves cardiac symptoms resulting from myocardial infiltration by lymphoma, including arrhythmias, heart failure, and chest pain. 18 F-FDG PET/CT serves as a reliable and indispensable imaging modality for assessing clinically staging NHL. CASE REPORT: We present a rare case involving a 72-year-old woman diagnosed with primary intracardiac diffuse large B-cell lymphoma...
2024: Frontiers in Medicine
https://read.qxmd.com/read/38561816/multiple-thrombi-mimicking-metastases-in-the-right-atrium-of-patients-with-non-hodgkin-s-lymphoma-diagnosed-by-multimodal-cardiac-imaging-one-case-report
#9
JOURNAL ARTICLE
Zhiqiang Hu, Shuai Yuan, Yun Mou
BACKGROUND: Right-side heart mass can be found incidentally on routine transthoracic echocardiography (TTE). Accurate diagnosis of cardiac mass often requires more than one imaging method. We present a mid-age woman with non-Hodgkin lymphoma who was found to have multiple right atrial masses mimicking metastases on routine TTE, which were finally diagnosed as thrombi by multimodal cardiac imaging. CASE PRESENTATION: A 52-year-old woman was diagnosed with primary mediastinal diffuse large B cell lymphoma (DLBCL) almost six months prior...
April 1, 2024: Journal of Cardiothoracic Surgery
https://read.qxmd.com/read/38557385/-advances-in-nutritional-support-for-children-undergoing-hematopoietic-stem-cell-transplantation
#10
JOURNAL ARTICLE
Ting Zhang, Mi-Zu Jiang
Hematopoietic stem cell transplantation (HSCT) is a therapeutic option for various potentially life-threatening malignant and non-malignant diseases in children, such as malignancies, immunodeficiency syndromes, severe aplastic anemia, and inherited metabolic disorders. During transplantation, many factors can affect the nutritional status of the children, including radiotherapy, chemotherapy, gastrointestinal disorders, graft-versus-host disease, and medications. Malnutrition has been associated with decreased overall survival and increased complications in children undergoing HSCT, making nutritional support a crucial component of their management...
March 15, 2024: Zhongguo Dang Dai Er Ke za Zhi, Chinese Journal of Contemporary Pediatrics
https://read.qxmd.com/read/38534448/phylogenetic-analysis-of-pyruvate-ferredoxin-oxidoreductase-a-redox-enzyme-involved-in-the-pharmacological-activation-of-nitro-based-prodrugs-in-bacteria-and-protozoa
#11
JOURNAL ARTICLE
Seth Duwor, Daniela Brites, Pascal Mäser
The present frontrunners in the chemotherapy of infections caused by protozoa are nitro-based prodrugs that are selectively activated by PFOR-mediated redox reactions. This study seeks to analyze the distribution of PFOR in selected protozoa and bacteria by applying comparative genomics to test the hypothesis that PFOR in eukaryotes was acquired through horizontal gene transfer (HGT) from bacteria. Furthermore, to identify other putatively acquired genes, proteome-wide and gene enrichment analyses were used...
March 9, 2024: Biology
https://read.qxmd.com/read/38519786/threonine-fuels-glioblastoma-through-yrdc-mediated-codon-biased-translational-reprogramming
#12
JOURNAL ARTICLE
Xujia Wu, Huairui Yuan, Qiulian Wu, Yixin Gao, Tingting Duan, Kailin Yang, Tengfei Huang, Shuai Wang, Fanen Yuan, Derrick Lee, Suchet Taori, Tritan Plute, Søren Heissel, Hanan Alwaseem, Michael Isay-Del Viscio, Henrik Molina, Sameer Agnihotri, Dennis J Hsu, Nu Zhang, Jeremy N Rich
Cancers commonly reprogram translation and metabolism, but little is known about how these two features coordinate in cancer stem cells. Here we show that glioblastoma stem cells (GSCs) display elevated protein translation. To dissect underlying mechanisms, we performed a CRISPR screen and identified YRDC as the top essential transfer RNA (tRNA) modification enzyme in GSCs. YRDC catalyzes the formation of N6 -threonylcarbamoyladenosine (t6 A) on ANN-decoding tRNA species (A denotes adenosine, and N denotes any nucleotide)...
March 22, 2024: Nature Cancer
https://read.qxmd.com/read/38512909/the-role-of-gapdh-in-the-selective-toxicity-of-cnp-in-melanoma-cells
#13
JOURNAL ARTICLE
Claudia von Montfort, Elif Aplak, Lara Ebbert, Chantal-Kristin Wenzel, Niklas P Klahm, Wilhelm Stahl, Peter Brenneisen
BACKGROUND: Malignant melanoma is the most aggressive form of skin cancer with a rather poor prognosis. Standard chemotherapy often results in severe side effects on normal (healthy) cells finally being difficult to tolerate for the patients. Shown by us earlier, cerium oxide nanoparticles (CNP, nanoceria) selectively killed A375 melanoma cells while not being cytotoxic at identical concentrations on non-cancerous cells. In conclusion, the redox-active CNP exhibited both prooxidative as well as antioxidative properties...
2024: PloS One
https://read.qxmd.com/read/38508617/feasibility-study-of-a-multimodal-prehabilitation-programme-in-women-receiving-neoadjuvant-therapy-for-breast-cancer-in-a-major-cancer-hospital-a-protocol
#14
JOURNAL ARTICLE
Suzanne J Grant, Shelley Kay, Judith Lacey, Sanjeev Kumar, Kim Kerin-Ayres, Justine Stehn, Maria Gonzalez, Sandra Templeton, Gillian Heller, Jane Cockburn, Sara Wahlroos, Ashanya Malalasekera, Cindy Mak, Susannah Graham
INTRODUCTION: Neoadjuvant therapy has become a standard treatment for patients with stage II/III HER2 positive and triple negative breast cancer, and in well-selected patients with locally advanced and borderline resectable high risk, luminal B breast cancer. Side effects of neoadjuvant therapy, such as fatigue, cardiotoxicity, neurotoxicity, anxiety, insomnia, vasomotor symptoms, gastrointestinal disturbance as well as a raft of immune-related adverse events, may impact treatment tolerance, long-term outcomes, and quality of life...
March 20, 2024: BMJ Open
https://read.qxmd.com/read/38507737/a-compound-that-inhibits-glycolysis-in-prostate-cancer-controls-growth-of-advanced-prostate-cancer
#15
JOURNAL ARTICLE
Takuma Uo, Kayode K Ojo, Cynthia C T Sprenger, Kathryn Soriano Epilepsia, B Gayani K Perera, Mamatha Damodarasamy, Shihua Sun, Soojin Kim, Hannah H Hogan, Matthew A Hulverson, Ryan Choi, Grant R Whitman, Lynn K Barrett, Samantha A Michaels, Linda H Xu, Vicky L Sun, Samuel L M Arnold, Haley J Pang, Matthew M Nguyen, Anna-Lena B G Vigil, Varun Kamat, Lucas B Sullivan, Ian R Sweet, Ram Vidadala, Dustin J Maly, Wesley C Van Voorhis, Stephen R Plymate
Metastatic castration-resistant prostate cancer remains incurable regardless of recent therapeutic advances. Prostate cancer tumors display highly glycolytic phenotypes as the cancer progresses. Non-specific inhibitors of glycolysis have not been utilized successfully for chemotherapy, because of their penchant to cause systemic toxicity. This study reports the preclinical activity, safety, and pharmacokinetics of a novel small molecule preclinical candidate, BKIDC-1553, with antiglycolytic activity. We tested a large battery of prostate cancer cell lines for inhibition of cell proliferation, in vitro...
March 20, 2024: Molecular Cancer Therapeutics
https://read.qxmd.com/read/38478170/fam83b-regulates-mitochondrial-metabolism-and-anti-apoptotic-activity-in-pulmonary-adenocarcinoma
#16
JOURNAL ARTICLE
Jiajia Wang, Panpan Li, Limin Sun, Jing Zhang, Ke Yue, Yan Wang, Xiaojuan Wu
Chemotherapy is an effective therapeutic modality; nevertheless, a significant proportion of patients diagnosed with lung adenocarcinoma (LUAD) demonstrate resistance to chemotherapy. Therefore, it is crucial to understand the potential regulatory mechanisms to develop novel treatment strategies. This study aims to understand how increased FAM83B expression impacts mitochondrial activity, cell apoptosis, and chemotherapy effectiveness in LUAD. Multiple assays, such as CCK8, wound healing, EdU, and transwell assays, were employed to confirm the augmented chemotherapy resistance, heightened cell proliferation, migration, and invasion caused by FAM83B overexpression in LUAD cells...
March 13, 2024: Apoptosis: An International Journal on Programmed Cell Death
https://read.qxmd.com/read/38474838/prevention-and-co-management-of-breast-cancer-related-osteoporosis-using-resveratrol
#17
REVIEW
Christine Meyer, Aranka Brockmueller, Constanze Buhrmann, Mehdi Shakibaei
Breast cancer (BC) is currently one of the most common cancers in women worldwide with a rising tendency. Epigenetics, generally inherited variations in gene expression that occur independently of changes in DNA sequence, and their disruption could be one of the main causes of BC due to inflammatory processes often associated with different lifestyle habits. In particular, hormone therapies are often indicated for hormone-positive BC, which accounts for more than 50-80% of all BC subtypes. Although the cure rate in the early stage is more than 70%, serious negative side effects such as secondary osteoporosis (OP) due to induced estrogen deficiency and chemotherapy are increasingly reported...
February 29, 2024: Nutrients
https://read.qxmd.com/read/38474411/emerging-role-of-autophagy-in-governing-cellular-dormancy-metabolic-functions-and-therapeutic-responses-of-cancer-stem-cells
#18
REVIEW
Meenakshi Tiwari, Pransu Srivastava, Sabiya Abbas, Janani Jegatheesan, Ashish Ranjan, Sadhana Sharma, Ved Prakash Maurya, Ajit Kumar Saxena, Lokendra Kumar Sharma
Tumors are composed of heterogeneous populations of dysregulated cells that grow in specialized niches that support their growth and maintain their properties. Tumor heterogeneity and metastasis are among the major hindrances that exist while treating cancer patients, leading to poor clinical outcomes. Although the factors that determine tumor complexity remain largely unknown, several genotypic and phenotypic changes, including DNA mutations and metabolic reprograming provide cancer cells with a survival advantage over host cells and resistance to therapeutics...
March 4, 2024: Cells
https://read.qxmd.com/read/38454614/microglia-and-glioblastoma-heterocellular-interplay-sustains-tumour-growth-and-proliferation-as-an-off-target-effect-of-radiotherapy
#19
JOURNAL ARTICLE
Cristiana Alberghina, Filippo Torrisi, Simona D'Aprile, Lucia Longhitano, Sebastiano Giallongo, Grazia Scandura, Giuliana Mannino, Stefania Mele, Maria Gabriella Sabini, Francesco P Cammarata, Giorgio Russo, Ali S Abdelhameed, Agata Zappalà, Debora Lo Furno, Rosario Giuffrida, Giovanni Li Volti, Daniele Tibullo, Nunzio Vicario, Rosalba Parenti
Glioblastoma (GBM), a WHO grade IV glioma, is a malignant primary brain tumour for which combination of surgery, chemotherapy and radiotherapy is the first-line approach despite adverse effects. Tumour microenvironment (TME) is characterized by an interplay of cells and soluble factors holding a critical role in neoplastic development. Significant pathophysiological changes have been found in GBM TME, such as glia activation and oxidative stress. Microglia play a crucial role in favouring GBM growth, representing target cells of immune escape mechanisms...
March 7, 2024: Cell Proliferation
https://read.qxmd.com/read/38444945/a-comprehensive-review-of-the-anticancer-effects-of-decursin
#20
REVIEW
Yueming Chu, Qiang Yuan, Hangyu Jiang, Liang Wu, Yutao Xie, Xiaofen Zhang, Lin Li
Cancer is a globally complex disease with a plethora of genetic, physiological, metabolic, and environmental variations. With the increasing resistance to current anticancer drugs, efforts have been made to develop effective cancer treatments. Currently, natural products are considered promising cancer therapeutic agents due to their potent anticancer activity and low intrinsic toxicity. Decursin, a coumarin analog mainly derived from the roots of the medicinal plant Angelica sinensis , has a wide range of biological activities, including anti-inflammatory, antioxidant, neuroprotective, and especially anticancer activities...
2024: Frontiers in Pharmacology
keyword
keyword
165104
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.